Intellia Therapeutics
NTLA
NTLA
130 hedge funds and large institutions have $557M invested in Intellia Therapeutics in 2018 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 44 increasing their positions, 27 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 112 → 130 (+18)
5.04% less ownership
Funds ownership: 67.35% → 62.31% (-5%)
57% less call options, than puts
Call options by funds: $4M | Put options by funds: $9.36M
Holders
130
Holding in Top 10
3
Calls
$4M
Puts
$9.36M
Top Buyers
| 1 | +$47M | |
| 2 | +$33.3M | |
| 3 | +$12.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$8.15M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.55M |
Top Sellers
| 1 | -$27.4M | |
| 2 | -$25.8M | |
| 3 | -$11.3M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$10.3M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$6.57M |